Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.

Pooni, Rajan S

Pooni, Rajan S.

Pooni RS; Newham University Hospital, London, UK.

Clin Med (Lond) ; 20(4): e59, 2020 07.

Article in English | MEDLINE | ID: covidwho-647446

Subject(s)

Betacoronavirus; Blood Coagulation Disorders/blood; Coronavirus Infections/complications; Fibrin Fibrinogen Degradation Products/metabolism; Pneumonia, Viral/complications; Thrombophilia/blood; Venous Thromboembolism/blood; Anticoagulants/therapeutic use; Biomarkers/blood; Blood Coagulation Disorders/virology; COVID-19; Case-Control Studies; Coronavirus Infections/blood; Heparin, Low-Molecular-Weight/therapeutic use; Humans; Pandemics; Partial Thromboplastin Time; Pneumonia, Viral/blood; Risk Factors; SARS-CoV-2; Thrombophilia/virology; Venous Thromboembolism/drug therapy; Venous Thromboembolism/virology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Blood Coagulation Disorders / Fibrin Fibrinogen Degradation Products / Coronavirus Infections / Thrombophilia / Venous Thromboembolism / Betacoronavirus Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Clin Med (Lond) Year: 2020 Document Type: Article Affiliation country: Clinmed.rib.20.4.2

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google